760-340-2540

Current Clinical Trials

INFINITY™ With ADAPTIS™ Technology Study
  1. David Friscia, MD
    David Friscia, MD
  2. for people 22 Years and up (full criteria)
  3. Rancho Mirage, CA
  4. study started March 2021
  5. David Friscia, MD
  6. Currently not accepting new patients

Description

Summary

The selected design is a multi-center, non-randomized, prospective study of 200 subjects in the US with up to 15 investigational sites and a potential for more as needed to meet the enrollment requirements. The study subjects included are those with ankle joints damaged by severe rheumatoid arthritis, post-traumatic disease, and degenerative arthritis and implanted with the INFINITY™ With ADAPTIS™ Technology Total Ankle System.

Official Title

INFINITY™ With ADAPTIS™ Technology Total Ankle Replacement Follow-Up (ITAR2)

Detailed Description

The selected design is a multi-center, non-randomized, prospective study of 200 subjects in the US with up to 15 investigational sites and a potential for more as needed to meet the enrollment requirements. The study subjects included are those with ankle joints damaged by severe rheumatoid arthritis, post-traumatic disease, and degenerative arthritis and implanted with the INFINITY™ With ADAPTIS™ Technology Total Ankle System.... more
less

The selected design is a multi-center, non-randomized, prospective study of 200 subjects in the US with up to 15 investigational sites and a potential for more as needed to meet the enrollment requirements. The study subjects included are those with ankle joints damaged by severe rheumatoid arthritis, post-traumatic disease, and degenerative arthritis and implanted with the INFINITY™ With ADAPTIS™ Technology Total Ankle System.

Keywords

Arthritis, Rheumatoid

Eligibility

for people 22 Years and up
Inclusion Criteria: Be over 22 years of age at the time of surgery; Diagnosed with unilateral and/or bilateral ankle joint disease; Diagnosed with ankle joint damage from rheumatoid arthritis, post-traumatic, or degenerative arthritis; Willing and able to consent to participate (written, informed consent; Willing and able to attend the requested follow-up visits; A clinical decision has been made to use INFINITY™ with ADAPTIS™ Technology Total Ankle System replacement prior to enrollment. Exclus... more
less

Inclusion Criteria: Be over 22 years of age at the time of surgery; Diagnosed with unilateral and/or bilateral ankle joint disease; Diagnosed with ankle joint damage from rheumatoid arthritis, post-traumatic, or degenerative arthritis; Willing and able to consent to participate (written, informed consent; Willing and able to attend the requested follow-up visits; A clinical decision has been made to use INFINITY™ with ADAPTIS™ Technology Total Ankle System replacement prior to enrollment. Exclusion Criteria: Subjects with an ankle condition, as determined by the investigator, to be an inappropriate candidate for a total ankle replacement; Subjects requiring revision total ankle replacement of the ankle being considered for study

Lead Scientist at Eisenhower Health

David Friscia, MD
David A. Friscia, MD joined Desert Orthopedic Center in 1990 to serve as director of the Center’s foot and ankle program. A Southern California native, Dr. Friscia was raised in Long Beach.“Foot and ankle surgery is especially challenging with the breadth and diversity of patients, conditions, and the need to be creative in your problem-solving.”He always had an interest in science and a desire to work with people, which is why he pursued medicine. He has been involved in impla... more
less

David A. Friscia, MD joined Desert Orthopedic Center in 1990 to serve as director of the Center’s foot and ankle program. A Southern California native, Dr. Friscia was raised in Long Beach.

“Foot and ankle surgery is especially challenging with the breadth and diversity of patients, conditions, and the need to be creative in your problem-solving.”

He always had an interest in science and a desire to work with people, which is why he pursued medicine. He has been involved in implant design and research. In addition, he is an Assistant Editor of the journal Foot & Ankle International.

Dr. Friscia graduated magna cum laude from Harvard University. Returning to California, he earned his Medical Degree from the University of California at San Francisco (UCSF). Following medical school in 1984, he spent five years as a resident at UCLA. In 1990, he went to the Mayo Clinic in Scottsdale, Arizona and received his subspecialty training as a fellow in foot and ankle surgery.

Dr. Friscia is a member of the American Medical Association, California Medical Association, American Orthopedic Foot and Ankle Society, North American Foot & Ankle Association and the American Academy of Orthopaedic Surgeons. He is a Diplomat of the American Board of Orthopedic Surgery and serves as an assistant clinical professor at USC where he teaches surgery residents and students.

He was recently President of the Riverside County Medical Association and has several terms as an officer of the Medical Staff of Eisenhower Medical Center. In addition, Dr. Friscia has served as Chairman and is President of Desert Orthopedic Center, and has served as Eisenhower Desert Orthopedic Center Medical Director. He also was Chairman of the Department of Surgery at Eisenhower Medical Center for four years and has served on numerous committees.

Clinical Study Details

  1. Currently not accepting new patients
  2. study started March 2021
  4. NCT04594993
  5. Observational
  6. December 23, 2024